Ticker Details
Bicara Therapeutics Inc. Common Stock
IPO Date:	September 13, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$848.02M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 3.58%
Avg Daily Range (30 D):	$0.42 | 2.58%
Avg Daily Range (90 D):	$0.46 | 2.76%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.34M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	388
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$1.02M
Avg Institutional Trade (90 D):	$1.68M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.49M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$1.38M
Avg Closing Volume:	100.65K

News

Feb 24, 2026 @ 9:01 PM Bicara Therapeutics Announces Proposed Public Offe... Source: Globe Newswire

Dec 15, 2025 @ 1:00 PM Bicara Therapeutics to Present at the J.P. Morgan ... Source: Claire Mazumdar

Dec 6, 2025 @ 1:00 PM Bicara Therapeutics’ Preliminary Phase 1b E... Source: Bicara Therapeutics

Oct 27, 2025 @ 12:30 PM Nanomedicine Breakthrough Technology Redefining Dr... Source: Prnewswire

Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$5.37	$-.67	$-.5
Diluted EPS	$5.37	$-.67	$-.5
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-121.52M	$-36.33M	$-27.39M
Operating Income / Loss	$-141.12M	$-40.68M	$-32.02M
Cost of Revenue
Net Cash Flow	$-349.09M	$-318.04M	$M
PE Ratio	3.11